Author:
Nabbi Raha,Woehlck Harvey J,Riess Matthias L
Abstract
Due to their beneficial reduction in morbidity and mortality angiotensin receptor blockers (ARBs) have become increasingly popular to treat hypertension. However, similar to angiotensin converting enzyme inhibitors, they can lead to severe hypotension in conjunction with general anesthesia and thus have been recommended to be withheld in the morning of surgery. Here, we present a 51 year old female who developed severe refractory hypotension after induction of general anesthesia, although she had discontinued her medication 24 hours preoperatively as instructed. Therefore, halting ARBs for more than 24 hours before surgery may be necessary. Heightened awareness of this potential interaction and recognizing the need to treat with vasopressin is required when ARB-induced hypotension occurs.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference11 articles.
1. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.;Z Israili;J Hum Hypertens.,2000
2. Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists.;S Brabant;Anesth Analg.,1999
3. Should the angiotensin II antagonists be discontinued before surgery?;M Bertrand;Anesth Analg.,2001
4. Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig.;F Ryckwaert;Br J Anaesth.,2002
5. Valsartan: more than a decade of experience.;H Black;Drugs.,2009
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献